Everence Capital Management Inc. Takes Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Everence Capital Management Inc. acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 11,990 shares of the company’s stock, valued at approximately $218,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Canada Pension Plan Investment Board bought a new stake in shares of Privia Health Group during the 2nd quarter worth $26,000. Nisa Investment Advisors LLC lifted its position in shares of Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after buying an additional 930 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after buying an additional 845 shares during the last quarter. Signaturefd LLC lifted its position in shares of Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after buying an additional 626 shares during the last quarter. Finally, Park Place Capital Corp lifted its position in shares of Privia Health Group by 115.4% during the 1st quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after buying an additional 1,335 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on PRVA. Evercore ISI dropped their price objective on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. KeyCorp assumed coverage on Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Robert W. Baird upped their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 target price on shares of Privia Health Group in a report on Wednesday, August 14th. Two research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $24.73.

Privia Health Group Trading Down 0.5 %

Shares of PRVA stock opened at $17.63 on Wednesday. The stock has a market cap of $2.10 billion, a price-to-earnings ratio of 117.53, a PEG ratio of 4.05 and a beta of 0.76. The stock has a 50-day moving average of $18.75 and a 200-day moving average of $18.30. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $24.35.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.02). Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. The company had revenue of $422.30 million during the quarter, compared to analyst estimates of $411.50 million. During the same period in the previous year, the company posted $0.06 EPS. The company’s quarterly revenue was up 2.2% on a year-over-year basis. Sell-side analysts forecast that Privia Health Group, Inc. will post 0.17 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 14.20% of the stock is currently owned by insiders.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.